Champlain Investment Partners’s Nordson NDSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $73.2M | Sell |
275,104
-191,624
| -41% | -$52.8M | 0.93% | 51 |
|
|
2025
Q4 | $112M | Sell |
466,728
-164,086
| -26% | -$38.6M | 1.14% | 33 |
|
|
2025
Q3 | $143M | Sell |
630,814
-185,301
| -23% | -$40.8M | 1.08% | 26 |
|
|
2025
Q2 | $175M | Buy |
816,115
+19,195
| +2% | +$3.82M | 1.22% | 16 |
|
|
2025
Q1 | $161M | Sell |
796,920
-63,510
| -7% | -$13.4M | 1.16% | 25 |
|
|
2024
Q4 | $180M | Buy |
860,430
+24,030
| +3% | +$5.94M | 1.14% | 24 |
|
|
2024
Q3 | $220M | Sell |
836,400
-17,255
| -2% | -$4.22M | 1.33% | 24 |
|
|
2024
Q2 | $198M | Sell |
853,655
-3,865
| -0.5% | -$974K | 1.21% | 24 |
|
|
2024
Q1 | $235M | Sell |
857,520
-155,010
| -15% | -$40.4M | 1.35% | 20 |
|
|
2023
Q4 | $267M | Sell |
1,012,530
-20,330
| -2% | -$4.71M | 1.59% | 10 |
|
|
2023
Q3 | $231M | Buy |
1,032,860
+48,795
| +5% | +$11.7M | 1.5% | 13 |
|
|
2023
Q2 | $244M | Buy |
984,065
+3,885
| +0.4% | +$866K | 1.5% | 14 |
|
|
2023
Q1 | $218M | Sell |
980,180
-18,810
| -2% | -$4.3M | 1.37% | 16 |
|
|
2022
Q4 | $237M | Sell |
998,990
-4,110
| -0.4% | -$938K | 1.52% | 11 |
|
|
2022
Q3 | $213M | Sell |
1,003,100
-21,195
| -2% | -$4.75M | 1.45% | 14 |
|
|
2022
Q2 | $207M | Buy |
1,024,295
+135,960
| +15% | +$29M | 1.34% | 17 |
|
|
2022
Q1 | $202M | Buy |
888,335
+8,082
| +0.9% | +$1.86M | 1.04% | 34 |
|
|
2021
Q4 | $225M | Sell |
880,253
-49,177
| -5% | -$12.6M | 1.02% | 28 |
|
|
2021
Q3 | $221M | Sell |
929,430
-33,257
| -3% | -$7.68M | 1.06% | 27 |
|
|
2021
Q2 | $211M | Sell |
962,687
-4,818
| -0.5% | -$1.02M | 1% | 33 |
|
|
2021
Q1 | $192M | Buy |
967,505
+459,332
| +90% | +$89.5M | 1% | 35 |
|
|
2020
Q4 | $102M | Buy |
508,173
+190,023
| +60% | +$38.2M | 0.59% | 73 |
|
|
2020
Q3 | $61M | Sell |
318,150
-155,785
| -33% | -$30M | 0.42% | 83 |
|
|
2020
Q2 | $89.9M | Sell |
473,935
-809,050
| -63% | -$137M | 0.65% | 63 |
|
|
2020
Q1 | $173M | Sell |
1,282,985
-12,095
| -0.9% | -$1.86M | 1.56% | 20 |
|
|
2019
Q4 | $211M | Sell |
1,295,080
-207,705
| -14% | -$32.8M | 1.54% | 13 |
|
|
2019
Q3 | $220M | Buy |
1,502,785
+131,350
| +10% | +$18.3M | 1.81% | 5 |
|
|
2019
Q2 | $194M | Buy |
1,371,435
+43,450
| +3% | +$5.98M | 1.63% | 7 |
|
|
2019
Q1 | $176M | Buy |
1,327,985
+24,220
| +2% | +$3.16M | 1.53% | 11 |
|
|
2018
Q4 | $156M | Buy |
1,303,765
+28,765
| +2% | +$3.53M | 1.58% | 13 |
|
|
2018
Q3 | $177M | Buy |
1,275,000
+56,365
| +5% | +$7.66M | 1.57% | 13 |
|
|
2018
Q2 | $156M | Buy |
1,218,635
+274,860
| +29% | +$36.3M | 1.51% | 14 |
|
|
2018
Q1 | $129M | Sell |
943,775
-30,565
| -3% | -$4.32M | 1.39% | 17 |
|
|
2017
Q4 | $143M | Buy |
974,340
+7,555
| +0.8% | +$971K | 1.61% | 12 |
|
|
2017
Q3 | $115M | Buy |
966,785
+799,057
| +476% | +$95.5M | 1.35% | 17 |
|
|
2017
Q2 | $20.3M | Buy |
+167,728
| New | +$20.5M | 0.25% | 107 |
|
Other funds holding NDSN
VCM
VPM
Champlain Investment Partners's NDSN Position: Q1 2026 in Review
Champlain Investment Partners reduced its Nordson (NDSN) stake by 41% in Q1 2026, selling an estimated $52.8M and leaving 275,104 shares worth $73.2M. The position accounts for 0.93% of the portfolio, ranked #51.
Champlain Investment Partners first reported a position in NDSN in Q2 2017 and has held it in 36 quarters since. The position peaked at $267M in Q4 2023. 708 funds tracked by Wall St. Rank hold NDSN as of Q1 2026.
- Champlain Investment Partners held 275,104 shares of Nordson worth $73.2M as of Q1 2026.
- Champlain Investment Partners sold 191,624 Nordson shares in Q1 2026, an estimated $52.8M.
- Nordson made up 0.93% of Champlain Investment Partners's portfolio in Q1 2026, its #51 holding.
- Champlain Investment Partners first reported a position in Nordson in Q2 2017 and has held it in 36 quarters since.
- Champlain Investment Partners's Nordson position peaked at $267M in Q4 2023.
- 708 funds tracked by Wall St. Rank held Nordson as of Q1 2026.
Based on Champlain Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.